NCT06251934
- Conditions
- BRAF-positive Metastatic Melanoma
- Locations
-
- Novartis East Hanover, New Jersey, United States
Clinical trial condition
BRAF-positive Metastatic Melanoma
Explore clinical trials studying BRAF-positive Metastatic Melanoma. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies